CalciMedica, Common Company Insiders

CALC Stock   3.09  0.08  2.52%   
CalciMedica, Common's insiders are aggressively buying. The analysis of the overall insider sentiment regarding CalciMedica, Common Stock suggests that all insiders are extremely bullish. CalciMedica, Common employs about 13 people. The company is managed by 13 executives with a total tenure of roughly 31 years, averaging almost 2.0 years of service per executive, having 1.0 employees per reported executive.

CalciMedica, Common's Insider Buying Vs Selling

100

 
Selling
 
Buying

Latest Trades

2024-12-06Fred A MiddletonAcquired 4800 @ 2.65View
2024-11-01Sanderling Venture Partners ViAcquired 86867 @ 3.75View
2024-08-27A. Rachel LehenyAcquired 1000 @ 4.19View
2024-08-23Robert N WilsonAcquired 54000 @ 3.72View
2024-08-21Eric W RobertsAcquired 5000 @ 4.04View
2024-06-27Robert N WilsonAcquired 8443 @ 3.23View
2024-04-01Eric W RobertsAcquired 746 @ 3.9View
2024-01-23Sanderling Venture Partners ViAcquired 243356 @ 3.7View
Monitoring CalciMedica, Common's insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CalciMedica, Common Stock. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

CalciMedica, Common Management Team Effectiveness

The company has return on total asset (ROA) of (0.6492) % which means that it has lost $0.6492 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.8376) %, meaning that it created substantial loss on money invested by shareholders. CalciMedica, Common's management efficiency ratios could be used to measure how well CalciMedica, Common manages its routine affairs as well as how well it operates its assets and liabilities. The current year's Return On Tangible Assets is expected to grow to -3.08. The current year's Return On Capital Employed is expected to grow to -2.93. As of January 20, 2025, Total Assets is expected to decline to about 10.4 M. In addition to that, Non Current Assets Total is expected to decline to about 495.9 K
The current year's Common Stock Shares Outstanding is expected to grow to about 5.4 M, whereas Net Loss is forecasted to decline to (13.7 M).

CalciMedica, Common Workforce Comparison

CalciMedica, Common Stock is number one stock in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 104,879. CalciMedica, Common adds roughly 13.0 in number of employees claiming only tiny portion of equities under Health Care industry.

CalciMedica, Common Insider Trading History

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific CalciMedica, Common insiders, such as employees or executives, is commonly permitted as long as it does not rely on CalciMedica, Common's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, CalciMedica, Common insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Buy/Sell Ratio# Purchases Trades# Sales TradesTotal Shares PurchasedTotal Shares Sold
2024-09-01
16.0
16
1
 526,761 
 11,761 
2009-12-01
43.0
43
1
 800,153 
 0.00 
2006-09-01
2.0
2
1
 529,992 
 264,996 
2006-03-01
1.0
1
1
 10,000 
 10,000 
2005-03-01
2.5455
28
11
 120,118 
 52,800 

CalciMedica, Common Notable Stakeholders

A CalciMedica, Common stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as CalciMedica, Common often face trade-offs trying to please all of them. CalciMedica, Common's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting CalciMedica, Common's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Kenneth StaudermanCoFounder OfficerProfile
Stefan MDCoFounder AdvisorProfile
Patrick HoganCoFounder AdvisorProfile
Anjana RaoCoFounder AdvisorProfile
Rachel LehenyCEO DirectorProfile
Michael MBAPresident COOProfile
MBA MBAPresident COOProfile
Eric RobertsChief BoardProfile
John JDGeneral CounselProfile
Raven MSChief OfficerProfile
Cindy ReiedenbergAccountantProfile
Daniel MBAInterim OfficerProfile
Sudarshan MDChief OfficerProfile

About CalciMedica, Common Management Performance

The success or failure of an entity such as CalciMedica, Common Stock often depends on how effective the management is. CalciMedica, Common management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of CalciMedica, management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the CalciMedica, management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last ReportedProjected for Next Year
Return On Tangible Assets(3.24)(3.08)
Return On Capital Employed(3.08)(2.93)
Return On Assets(3.24)(3.08)
Return On Equity(4.84)(4.60)
Please note, the presentation of CalciMedica, Common's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, CalciMedica, Common's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of CalciMedica, Common's management manipulating its earnings.

CalciMedica, Common Workforce Analysis

Traditionally, organizations such as CalciMedica, Common use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare CalciMedica, Common within its industry.

CalciMedica, Common Manpower Efficiency

Return on CalciMedica, Common Manpower

Revenue Per Employee0.0
Revenue Per Executive0.0
Net Loss Per Employee2.6M
Net Loss Per Executive2.6M
Working Capital Per Employee582.8K
Working Capital Per Executive582.8K

Complementary Tools for CalciMedica, Stock analysis

When running CalciMedica, Common's price analysis, check to measure CalciMedica, Common's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CalciMedica, Common is operating at the current time. Most of CalciMedica, Common's value examination focuses on studying past and present price action to predict the probability of CalciMedica, Common's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CalciMedica, Common's price. Additionally, you may evaluate how the addition of CalciMedica, Common to your portfolios can decrease your overall portfolio volatility.
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges